At the Lagos University Teaching Hospital Haemophilia Treatment Centre (HTC) in Lagos, Nigeria, clinical management was based mainly on presumptions for many years. Although laboratory...
The WFH Humanitarian Aid Program is changing lives of patients with bleeding disorders in Nepal. Donated factor provided by the Program to the local national...
On October 16, 2020 during the World Federation of Hemophilia (WFH) Annual Meeting of the General Assembly, the Fiji Haemophilia Foundation (FHF) was accredited as...
On January 7, 2021, the culmination of a multiyear international collaboration was published in Blood Advances: ASH ISTH NHF WFH Guidelines on the Diagnosis of...
On October 16, 2020, during the World Federation of Hemophilia (WFH) Annual Meeting of the General Assembly, the Associação Liga dos Amigos de Doentes Hematológicos...
Giving Tuesday began in 2012 with a simple but powerful idea: create a day that encourages people to do good. It has since grown into...
In 2016, Egypt was enrolled in a phase II of the WFH Global Alliance for Progress (GAP) Program to help improve diagnosis and advocacy in...
Updated 23 December 2020 BioMarin announces no dosing in their hemophilia gene therapy trials temporarily to permit better understanding of the UniQure hemophilia B participant...
Guidance from the World Federation of Hemophilia (WFH), European Association for Haemophilia and Allied Disorders (EAHAD), European Haemophilia Consortium (EHC), and U.S. National Hemophilia Foundation...
The World Federation of Hemophilia (WFH) exists because we believe—as do you—that where you live should never determine your access to care. Every day we...
Sanofi has announced plans to resume dosing in its ongoing fitusiran clinical studies, lifting the voluntary global hold that was initiated on October 30 to...
Have a happy, healthy and safe new year. Que tenga un Año Nuevo feliz, saludable y seguro. Que cette nouvelle année vous apporte bonheur et...